NewEdge Advisors’s CureVac CVAC Stock Holding History

NewEdge Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-129	Closed	-$695	–	4252
2025 Q3	$695	Hold	129	–	–	﹤0.01%	3912
2025 Q2	$700	Hold	129	–	–	﹤0.01%	3755
2025 Q1	$357	Hold	129	–	–	﹤0.01%	3753
2024 Q4	$440	Hold	129	–	–	﹤0.01%	3673
2024 Q3	$379	Hold	129	–	–	﹤0.01%	3632
2024 Q2	$439	Hold	129	–	–	﹤0.01%	3582
2024 Q1	$391	Hold	129	–	–	﹤0.01%	3607
2023 Q4	$543	Hold	129	–	–	﹤0.01%	3527
2023 Q3	$881	Sell	129 -4	-3%	-$35	﹤0.01%	3191
2023 Q2	$1.39K	Sell	133 -150	-53%	-$1.34K	﹤0.01%	3184
2023 Q1	$1.97K	Buy	283 +150	+113%	+$1.31K	﹤0.01%	3032
2022 Q4	$1	Buy	+133	New	+$983	﹤0.01%	3994

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

NewEdge Advisors's CVAC Position: Q4 2025 in Review

NewEdge Advisors sold out of CureVac (CVAC) in Q4 2025, closing a stake of 129 shares — an estimated $695 sold.

NewEdge Advisors first reported a position in CVAC in Q4 2022 and held it in 12 quarters. The position peaked at $1.97K in Q1 2023. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

NewEdge Advisors reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
NewEdge Advisors sold 129 CureVac shares in Q4 2025, an estimated $695.
NewEdge Advisors first reported a position in CureVac in Q4 2022 and held it in 12 quarters.
NewEdge Advisors's CureVac position peaked at $1.97K in Q1 2023.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.